Study guide
5.2 Non-Convulsive Status Epilepticus (NCSE) & Salzburg Criteria
ABRET Certified Long Term Monitoring Technologist CLTM
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pre-Study Preparation & Clinical Indications
1.1 Clinical Indications for Long-Term Monitoring 1.2 Patient History, Clinical Assessment & Neurological Evaluation 1.3 Recording Strategy, Protocol Planning & Patient Communication
2 Chapter 2: Electrodes, Montages & Technical Setup
2.1 Electrode Selection, Application & Scalp Integrity 2.2 True and Modified Montages for LTM 2.3 Instrument Settings, Calibration & Differential Amplification 2.4 Signal Integrity, Impedance Monitoring & Artifact Troubleshooting
3 Chapter 3: Seizure Classification, Semiology & Clinical Events
3.1 ILAE 2017 Seizure Classification Framework 3.2 Seizure Semiology & Ictal Phenotypes 3.3 Differentiating Epileptic vs Non-Epileptic Events 3.4 Event Button Workflow, Clinical Testing & Ictal Observation
4 Chapter 4: EEG Waveform Identification & Interictal Discharges
4.1 Normal Variants and Benign Epileptiform Patterns 4.2 Interictal Epileptiform Discharges (IEDs) 4.3 Electrographic and Electroclinical Seizure Patterns
5 Chapter 5: ICU Continuous EEG & Critical Care Monitoring
5.1 ACNS Standardized Critical Care Terminology 5.2 Non-Convulsive Status Epilepticus (NCSE) & Salzburg Criteria 5.3 Coma Patterns, Burst Suppression & Prognostication 5.4 Quantitative EEG (qEEG) Trends & ICU Trending Tools
6 Chapter 6: Age-Specific Monitoring: Neonatal & Pediatric LTM
6.1 Neonatal EEG & Continuous Monitoring 6.2 Pediatric Epilepsy Syndromes in the EMU 6.3 Pediatric Technical Considerations & Behavioral Strategies
7 Chapter 7: Invasive Intracranial Monitoring & Functional Mapping
7.1 Intracranial Recording Modalities (Grids, Strips, SEEG) 7.2 Extraoperative Functional Brain Mapping & Cortical Stimulation 7.3 Somatosensory Evoked Potentials (SEPs) & Central Sulcus Localization
8 Chapter 8: Provocative Testing & In-Study Interventions
8.1 Activation Procedures in LTM (HV, Photic, Sleep Deprivation) 8.2 Medication Withdrawal & Provocation Protocols 8.3 Emergency Escalation & Status Epilepticus Management
9 Chapter 9: Post-Study Procedures, Technical Reporting & Localization
9.1 Technical Summary & Technologist Reporting 9.2 Data Review, Reformatting & Montage Re-montaging 9.3 Localization Techniques & Dipole Principles 9.4 Study Completion, Electrode Removal & Infection Prevention
10 Chapter 10: Data & Equipment Management
10.1 Video-EEG Synchronization & Audio-Visual Systems 10.2 Data Pruning, Clipping & Archiving 10.3 Network Infrastructure, Server Systems & Hardware Maintenance
11 Chapter 11: Ethics, Patient Safety & Professional Standards
11.1 Patient Safety Protocols & Fall Prevention in the EMU 11.2 Regulatory Compliance: HIPAA, HITECH & Video Privacy 11.3 CPT and ICD-10 Coding for LTM Services 11.4 ABRET Code of Ethics & Professional Practice Standards
5.2 Non-Convulsive Status Epilepticus (NCSE) & Salzburg Criteria
Key Takeaways Explain This Topic AI
Non-Convulsive Status Epilepticus (NCSE) is defined as continuous electrographic seizure activity lasting ≥10 minutes or recurrent discrete seizures occupying ≥20% of any 60-minute recording without prominent convulsive motor manifestations.
Under the 2015 Salzburg Criteria for patients without known epileptic encephalopathy, NCSE is confirmed if epileptiform discharges are >2.5 Hz, OR if discharges are ≤2.5 Hz / rhythmic delta-theta >0.5 Hz accompanied by subtle clinical signs, spatio-temporal evolution (≥0.5 Hz frequency change, morphology, or spatial propagation), or rapid clinical and electrographic improvement following an IV anti-seizure medication (ASM) challenge.
Electroclinical dissociation occurs in up to 15–30% of patients successfully treated for generalized convulsive status epilepticus, where overt motor convulsions terminate but severe non-convulsive electrical status epilepticus persists unabated.
Metabolic GPDs with triphasic morphology (hepatic/uremic encephalopathy) must be differentiated from ictal NCSE by characteristic front-to-occipital Phase 2 lag (20–100 ms), blunt waveform morphology, static frequency (1–2 Hz), and lack of clinical awakening after benzodiazepines.
The Salzburg IV ASM Challenge Test requires continuous, synchronized video-EEG recording with precise time-stamping of medication injection, followed by minute-by-minute documentation of electrographic discharge attenuation and clinical cognitive/motor recovery.
Last updated: August 2026
5.2 Non-Convulsive Status Epilepticus (NCSE) & Salzburg Criteria
Non-Convulsive Status Epilepticus (NCSE) is an acute medical and neurological emergency characterized by continuous or fluctuating epileptiform electrographic activity associated with altered mental status and variable subtle clinical manifestations, but lacking prominent convulsive motor movements. In the intensive care unit, NCSE is diagnosed in 15% to 40% of comatose patients with acute brain injury, including traumatic brain injury (TBI), aneurysmal subarachnoid hemorrhage (aSAH), ischemic or hemorrhagic stroke, and central nervous system infections.
Because prolonged non-convulsive ictal activity leads to sustained excitotoxic calcium influx, mitochondrial exhaustion, hyperpyrexia, and irreversible neuronal death, rapid diagnostic identification and therapeutic intervention are essential. For the LTM technologist, recognizing NCSE on continuous EEG and executing standardized diagnostic protocols (such as the Salzburg Criteria and the IV anti-seizure medication challenge) is a primary life-safety competency.
1. Spectrum, Pathophysiology & Clinical Semiology
NCSE is not a single disease entity, but rather an umbrella term covering distinct electroclinical syndromes across diverse clinical contexts. +---------------------------------------------------------------------------------------------------------+
- | NCSE CLINICAL SPECTRUM & SUBTYPES |
- | |
- | NCSE Subtype Patient Population / Context Clinical Presentation & Mortality |
- | +------------------------+ +-------------------------------------+ +----------------------------------+ |
- | | NCSE in Coma | Severely brain-injured ICU patients | Deep coma, subtle ocular/facial | |
- | | (Comatose NCSE) | (anoxia, TBI, ICH, severe sepsis) | twitching; high mortality (40–60%)| |
- | +------------------------+ +-------------------------------------+ +----------------------------------+ |
- | | Focal NCSE with | Patients with focal epilepsy, stroke, | Clouded consciousness, aphasia, | |
- | | Impaired Awareness | or focal structural lesions | staring, automatisms; mod. mortal| |
- | +------------------------+ +-------------------------------------+ +----------------------------------+ |
- | | Absence Status | Idiopathic Generalized Epilepsy (IGE) | Waxing/waning confusion, staring,| |
- | | Epilepticus (ASE) | or older adults (de novo absence) | preserved reflexes; low mortality| |
- | +------------------------+ +-------------------------------------+ +----------------------------------+ |
- | | NCSE in Epileptic | Severe developmental encephalopathies | Exacerbation of baseline cognitive| |
- | | Encephalopathy | (Lennox-Gastaut, Dravet syndrome) | deficits, motor slowing; variable| |
- | +------------------------+ +-------------------------------------+ +----------------------------------+ |
- +---------------------------------------------------------------------------------------------------------+
- Electroclinical Dissociation
A critically important phenomenon in emergency critical care is electroclinical dissociation . In patients presenting with generalized convulsive status epilepticus (GCSE), standard first-line therapies (such as IV lorazepam or midazolam) frequently eliminate overt motor convulsions (tonic-clonic jerking). However, in 15% to 30% of these cases , the brain remains in continuous electrographic status epilepticus. [ THE PHENOMENON OF ELECTROCLINICAL DISSOCIATION ]
- STAGE 1: Overt Convulsive Status STAGE 2: Pharmacological Motor Arrest
- +--------------------------------------+ +--------------------------------------+
- | - Rhythmic generalized clonic jerks | | - Motor jerking terminates |
- | - Hyperdynamic sympathetic surge |-->| - Patient appears comatose / quiet |
- | - Continuous bilateral spike-wave EEG| | - Clinician assumes seizure resolved |
- +--------------------------------------+ +--------------------------------------+
- |
- v
- STAGE 3: Persistent Electrographic NCSE
- +--------------------------------------+
- | - Ongoing ictal discharge on cEEG |
- | - Unchecked neuronal excitotoxicity |
- | - Secondary brain injury progresses |
- +--------------------------------------+
- Subtle Semiological Manifestations of NCSE
In non-convulsive status epilepticus, motor manifestations are frequently microscopic and easily overlooked during routine bedside nursing:
Ocular Signs: Rhythmic nystagmus (horizontal, vertical, or rotatory), rhythmic eyelid flutter or blinking, sustained tonic eye deviation, hippus (rhythmic pupillary dilation and contraction).
Facial / Perioral Signs: Rhythmic unilateral twitching of the corner of the mouth, subtle chin quivering, repetitive tongue smacking or chewing movements.
Limb / Axial Signs: Subtle distal myoclonus (finger tapping), perseverative picking at blankets, catatonic rigidity.
Cognitive / Behavioral Signs: Acute fluctuating delirium, speech arrest / continuous paraphasic aphasia, unprovoked laughter (gelastic status), staring spells with profound amnesia.
2. The 2015 Salzburg Criteria for NCSE
Prior to 2015, the definition of NCSE suffered from considerable diagnostic variability. To establish an evidence-based diagnostic standard, the Salzburg International Consensus Conference developed the Salzburg Criteria for NCSE , which are widely used alongside current ACNS critical-care terminology, the clinical context, treatment response, and physician interpretation. +---------------------------------------------------------------------------------------------------------+
- | SALZBURG CRITERIA FOR NCSE (2015) |
- | |
- | [ PATIENT WITHOUT KNOWN EPILEPTIC ENCEPHALOPATHY ] |
- | | |
- | Is discharge frequency > 2.5 Hz? |
- | / \ |
- | YES NO |
- | / \ |
- | +--------------------------+ Are discharges <= 2.5 Hz OR |
- | | DEFINITE NCSE | rhythmic activity > 0.5 Hz? |
- | +--------------------------+ / \ |
- | YES NO ---> [ NOT NCSE ] |
- | / |
- | Does the pattern satisfy AT LEAST ONE of the following: |
- | (A) Subtle clinical ictal signs time-locked to EEG? |
- | (B) Spatio-temporal evolution in frequency, morphology, or field? |
- | (C) Clinical AND electrographic improvement after rapid IV ASM? |
- | / \ |
- | YES NO |
- | / \ |
- | +--------------------------+ +--------------------------+ |
- | | DEFINITE NCSE | | NCSE NOT CONFIRMED | |
- | +--------------------------+ | (Consider IIC / Enceph.) | |
- | +--------------------------+ |
- +---------------------------------------------------------------------------------------------------------+
- Detailed Salzburg Criteria Breakdown
- A. In Patients WITHOUT Known Epileptic Encephalopathy
Epileptiform Discharges >2.5 Hz: Continuous or recurrent periodic discharges (LPDs, GPDs, BIPDs) or spike-and-wave complexes at a frequency >2.5 Hz for ≥10 seconds (or ≥20% of a 60-minute recording). Confirms Definite NCSE without requiring additional modifiers.
Epileptiform Discharges ≤2.5 Hz OR Rhythmic Delta/Theta Activity >0.5 Hz , PLUS at least one of the following secondary criteria:
Subtle Clinical Ictal Manifestations: Definite clinical signs (e.g., rhythmic eyelid myoclonus, nystagmoid jerks, subtle facial twitching) occurring strictly time-locked to the electrographic discharges.
Spatio-Temporal Evolution: Dynamic progression meeting the definition of electrographic evolution (defined as dynamic changes in frequency ≥0.5 Hz to ≥1.0 Hz, progressive change in waveform morphology, or spatial propagation across ≥2 adjacent electrodes).
Response to Rapid IV Anti-Seizure Medication (The ASM Test): Prompt resolution of the epileptiform discharges accompanied by both electrographic background improvement AND clinical neurological improvement (arousal, following commands, verbalization).
Important
Possible NCSE vs. Definite NCSE in the ASM Test: If administration of an IV anti-seizure medication (or benzodiazepine) abolishes the periodic/rhythmic discharges on EEG but produces no clinical cognitive or behavioral improvement , the pattern is classified as Possible NCSE (or an encephalopathic pattern on the Ictal-Interictal Continuum) rather than Definite NCSE.
B. In Patients WITH Known Epileptic Encephalopathy
In patients with pre-existing encephalopathy (e.g., Lennox-Gastaut syndrome) who have continuous baseline epileptiform abnormalities:
There must be a clear increase in frequency or prominence of discharges compared to baseline, accompanied by an observable clinical deterioration in level of consciousness or motor function, OR
A definitive clinical and electrographic response to IV ASM administration.
3. The Triphasic Wave / GPDs vs. NCSE Dilemma
A frequent critical care dilemma is distinguishing Generalized Periodic Discharges with Triphasic Morphology (classically caused by toxic-metabolic encephalopathy, such as hepatic failure, uremia, hyperammonemia, lithium toxicity, or baclofen toxicity) from true non-convulsive status epilepticus. +---------------------------------------------------------------------------------------------------------+
- | GPDs (TRIPHASIC MORPHOLOGY) VS. NON-CONVULSIVE SEIZURES |
- | |
- | Feature Metabolic GPDs (Triphasic Waves) Electrographic NCSE (Ictal) |
- | +-------------------------+ +-------------------------------------+ +-------------------------------+ |
- | | Typical Frequency | 1.0–2.0 Hz (rarely >2.0 Hz) | Frequently >2.5 Hz or evolving | |
- | +-------------------------+ +-------------------------------------+ +-------------------------------+ |
- | | Waveform Morphology | Triphasic (Phase 1 neg, Phase 2 pos, | Sharp, spike-wave, polyspikes, | |
- | | | Phase 3 slow neg; blunt contour) | sharp crests without phase lag | |
- | +-------------------------+ +-------------------------------------+ +-------------------------------+ |
- | | Anterior-Posterior Lag | Present: Phase 2 demonstrates front- | Absent: Instantaneous bilateral | |
- | | | to-occipital lag (20–100 ms) | or focal propagation | |
- | +-------------------------+ +-------------------------------------+ +-------------------------------+ |
- | | Spatio-Temporal Evol. | Static, non-evolving; fluctuations | Dynamic evolution in frequency, | |
- | | | driven by metabolic state | morphology, and spatial field | |
- | +-------------------------+ +-------------------------------------+ +-------------------------------+ |
- | | Superimposed Fast (+F) | Rare (typically low beta/fast absent) | Common (+F, +FS, +FR) | |
- | +-------------------------+ +-------------------------------------+ +-------------------------------+ |
- | | Clinical Correlation | Diffuse lethargy, asterixis, jaundice | Subtle nystagmus, twitching | |
- | +-------------------------+ +-------------------------------------+ +-------------------------------+ |
- | | Response to IV Benzodiazep| EEG slows/attenuates transiently; | Prompt clinical arousal + | |
- | | (ASM Challenge) | NO clinical awakening (deepens coma) | electrographic normalization | |
- | +-------------------------+ +-------------------------------------+ +-------------------------------+ |
- +---------------------------------------------------------------------------------------------------------+
- 4. Urgent Technologist Protocol & The IV ASM Challenge Test
When a pattern suspicious for NCSE is encountered in the ICU, the LTM technologist must execute a rigorous, standardized rapid-escalation and testing workflow. +---------------------------------------------------------------------------------------------------------+
- | TECHNOLOGIST NCSE ESCALATION & ASM WORKFLOW |
- | |
- | STEP 1: Immediate Recognition & Escalation |
- | - Identify rhythmic/periodic pattern meeting Salzburg criteria (>2.5 Hz or <=2.5 Hz with evolution) |
- | - Directly notify Neuro-Intensivist / On-Call Epileptologist within <5 minutes |
- | |
- | STEP 2: Bedside Clinical & Semiological Examination |
- | - Video Camera: Zoom and focus directly on patient's face, eyes, and hands |
- | - Examine for subtle nystagmus, eyelid flutter, perioral myoclonus, gaze deviation |
- | - Standardized cognitive testing: Level of consciousness, command following, word repetition |
- | |
- | STEP 3: The Standardized IV ASM Challenge Test Protocol |
- | - Baseline Recording: Ensure 5–10 minutes of stable, artifact-free baseline cEEG |
- | - Precise Event Markers: Place annotation at exact second of IV injection start and completion |
- | (e.g., '*IV Lorazepam 2mg IV Push Started*', '*IV Push Complete*') |
- | - Time-Locked Video Assessment: Repeat verbal commands and sensory stimulation at: |
- | * 30 seconds post-injection |
- | * 1 minute, 2 minutes, 5 minutes, 10 minutes, and 15 minutes post-injection |
- | - Document Vital Signs & Safety: Monitor respiratory rate, SpO2, and blood pressure |
- | |
- | STEP 4: Technical Summary & Post-Test Reporting |
- | - Annotate electrographic change (e.g., '*Pattern abolished; diffuse 6 Hz theta emerging*') |
- | - Annotate clinical state (e.g., '*Patient opens eyes to voice, follows 2-step commands*') |
- +---------------------------------------------------------------------------------------------------------+
- 5. Clinical Traps & High-Yield Exam Pitfalls
Caution
Critical NCSE Traps for the CLTM Exam:
Trap 1: The 'Electrographic Sedation Fallacy': Administering IV midazolam or propofol will electrographically suppress virtually ANY high-amplitude cerebral discharge, including metabolic triphasic waves and severe encephalopathic slow waves. Electrographic attenuation alone does not prove NCSE; true confirmation requires concomitant clinical neurological improvement or unequivocal prior electrographic evolution.
Trap 2: Ignoring Subclinical Seizures in Post-Anoxic Patients: Post-cardiac arrest patients undergoing Targeted Temperature Management (TTM) or receiving neuromuscular paralytics (such as vecuronium or rocuronium) cannot exhibit motor twitching. In paralyzed patients, continuous EEG is the only modality capable of detecting NCSE.
Trap 3: Inadequate Baseline Documentation during ASM Trials: If an ASM is pushed without establishing a high-quality, artifact-free 5-minute pre-medication baseline, it is impossible to determine whether subsequent EEG changes represent true drug-induced ictal termination or spontaneous baseline fluctuation.